Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-09-19
2006-09-19
Wang, Andrew (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091500, C435S091500, C356S301000, C356S322000, C356S364000
Reexamination Certificate
active
07108970
ABSTRACT:
The invention concerns arrays comprising hundreds, thousands, to hundreds of thousands of samples and methods for screening thereof. These methods are useful to optimize, select, and discover compounds, compositions, or conditions that prevent, inhibit, induce, modify, or reverse physical-state transitions, particularly in-vivo physical-state transitions relating to disease causing processes. Such compounds, compositions, or conditions can be exploited to treat (e.g., reverse) or prevent the disease itself, the cause of the disease, or the symptoms of the disease.
REFERENCES:
patent: 3899011 (1975-08-01), Curtiss
patent: 3932131 (1976-01-01), Rolfo-Fontana
patent: 4399687 (1983-08-01), Collins
patent: 4835711 (1989-05-01), Hutchins et al.
patent: 4877745 (1989-10-01), Hayes et al.
patent: 5417923 (1995-05-01), Bojanic et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5463564 (1995-10-01), Agrafiotis et al.
patent: 5574656 (1996-11-01), Agrafiotis et al.
patent: 5658802 (1997-08-01), Hayes et al.
patent: 5684711 (1997-11-01), Agrafiotis et al.
patent: 5744305 (1998-04-01), Fodor et al.
patent: 5763278 (1998-06-01), Sickinger et al.
patent: 5776348 (1998-07-01), Selengut et al.
patent: 5807522 (1998-09-01), Brown et al.
patent: 5832182 (1998-11-01), Zhang et al.
patent: 5843767 (1998-12-01), Beattie
patent: 5859703 (1999-01-01), Aldridge et al.
patent: 5901069 (1999-05-01), Agrafiotis et al.
patent: 5928952 (1999-07-01), Hutchins et al.
patent: 5956137 (1999-09-01), Lim et al.
patent: 5999255 (1999-12-01), Dupee et al.
patent: 6003029 (1999-12-01), Agrawal et al.
patent: 6100901 (2000-08-01), Mohda et al.
patent: 6140643 (2000-10-01), Brown et al.
patent: 6175816 (2001-01-01), Flavin et al.
patent: 6267935 (2001-07-01), Hol et al.
patent: 6296673 (2001-10-01), Santarsiero et al.
patent: 6297935 (2001-10-01), Yoo et al.
patent: 6327334 (2001-12-01), Murray
patent: 6331440 (2001-12-01), Nordstedt et al.
patent: 6333501 (2001-12-01), Labrenz
patent: 6421553 (2002-07-01), Costa et al.
patent: 6434490 (2002-08-01), Agrafiotis et al.
patent: 6487523 (2002-11-01), Jarman et al.
patent: 2001/0016631 (2001-08-01), Freitag et al.
patent: 2001/0036640 (2001-11-01), D'Amico
patent: 2001/0055775 (2001-12-01), Shultz et al.
patent: 2002/0023507 (2002-02-01), Hajduk et al.
patent: 2002/0029621 (2002-03-01), Hajduk et al.
patent: 2002/0032531 (2002-03-01), Mansky et al.
patent: 2002/0037647 (2002-03-01), Hwang et al.
patent: 2002/0183938 (2002-12-01), Kobylecki et al.
patent: 2003/0022234 (2003-01-01), Cawse et al.
patent: 2003/0033088 (2003-02-01), Agrafiotis et al.
patent: 2003/0119060 (2003-06-01), Desrosiers et al.
patent: 2003/0124028 (2003-07-01), Carlson et al.
patent: 2003/0124610 (2003-07-01), Kvanheim et al
patent: 2003/0219906 (2003-11-01), Giaquinta et al.
patent: 0553 539 (1992-10-01), None
patent: 0 807 811 (1997-04-01), None
patent: 0 882 500 (1997-10-01), None
patent: 0 921 396 (1998-11-01), None
patent: 1 174 183 (1999-08-01), None
patent: 1 174 185 (2001-07-01), None
patent: 1 186 892 (2001-08-01), None
patent: 94/11489 (1994-05-01), None
patent: 96/06842 (1996-03-01), None
patent: 96/16078 (1996-05-01), None
patent: 98/40159 (1998-09-01), None
patent: 98/47613 (1998-10-01), None
patent: 98/52614 (1998-11-01), None
patent: 99/04247 (1999-01-01), None
patent: 99/06814 (1999-02-01), None
patent: 99/08112 (1999-02-01), None
patent: 99/45379 (1999-09-01), None
patent: 99/45389 (1999-09-01), None
patent: 00/03240 (2000-01-01), None
patent: 00/29987 (2000-05-01), None
patent: WO 01/51919 (2001-01-01), None
patent: 01/34290 (2001-05-01), None
patent: WO 01/51919 (2001-07-01), None
patent: 02/31477 (2002-04-01), None
patent: 03/014732 (2003-02-01), None
Leskovar, P.; Vogel, E.; Rozehnal, A. Urolithiasis Relat. Clin. Res., [Proc. Int. Symp.] 5th (1985), Meeting Date 1984, 627-30.
Klein, J.; Lehmann, C. W.; Schmidt, H.-W.; Maier, W. F. “Combinatorial Material Libraries on the Microgram Scale with an Example of Hydrothermal Synthesis” Angew. Chem. Int. Ed. 1998, 37(24), 3369-3372.
Jandeleit, B.; Schaefer, D. J.; Powers, T.S.; Turner, H.W.; Weinberg, W. H. “Combinatorial Materials Science and Catalysis” Angew. Chem. Int. Ed. 1999 38, 2495-2532.
Emiabata-Smith, D. F., Crookes, D. L.; Owen, M.R. “A practical approach to accelerated process screening and optimization” Organic Process Research & Development 1999, 3, 281-288.
Findlay, W. P.; Bugay, D. E. “Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms” Journal of Pharmaceutical and Biomedical Analysis 1998, 16, 921-930.
Addadi, “Growth and dissolution of organic crystals in the presence of organic crystals in the presence of additives stereochemistry and materials science”Angew. Chem., 1985, vol. 97, pp. 476-496.
Beiswanger et al. “The Prevalence and Incidence of Dental Calculus in Adults”J. Clin. Dent., 1989, vol. 1, pp. 55-58.
Berkovitch-Yellin et al. “Morphology Engineering of Organic Crystals with the Assistance of ‘Tailor-Made’ Growth Inhibitors”North Western Branch Papers, 1985, No. 3, pp. 1.1-1.22.
Fleisch et al., “Influence of Pyrophosphate on the Transformation of Amorphous to Crystalline Calcium Phosphate”Calc. Tiss. Res., 1968, vol. 2, pp. 49-59.
Gadamasetti, K.G. (editor),Process Chemistry in the Pharmaceutical Industry, Marcel Dekker, Inc., N.Y., N.Y., 1999, pp. 372-388.
Mandel and Gaffar “Calculus revisited: A review”J. Clin. Periodontol., 1986, vol. 13, pp. 249-257.
Popovitz-Biro et al. “Self-Organization of Molecules en Route to Crystal Formation,”From Simplicity Complexity Chem.—Beyond, Pt. 1,1996, pp. 85-98.
Reixach, et al. “Inhibition of β-Amyloid-Induced Neurotoxicity by Imidazopyridoindoles Derived from a Synthetic Combinatorial Library”J. Struct. Biol., 2000, vol. 130, pp. 247-258.
Suomi et al. “A Clinical Trial of a Calculus-Inhibitory Dentifrice,”J. Periodontol., 1974, vol. 45, No. 3, pp. 139-145.
Tabak et al., “Role of Salivary Mucins in the Protection of the Oral Cavity”Journal of Oral Pathology, 1982, vol. 11, pp. 1-17.
Toto and Rapp “A Clinical Comparison of a New Low Abrasive Dentifrice with Intermediate and High Abrasive Dentifrices”J. Periodontol., 1972, vol. 43, No. 8, pp. 492-494.
Weissbuch et al. “Application of Cryo-Electron Microscopy to Self-Assembled Mixed Monolayers for Studying Crystallinity and Twinning”J. Phys. Chem., 1993, vol. 97, pp. 8692-8695.
Weissbuch et al. “Mixed Monolayers for the Design of Structured Surfaces to Induce Oriented 3-D Crystallization”J. Phys. Chem., 1993, vol. 97, pp. 12848-12857.
Weissbuch et al. “Structural Changes in Amphiphilic Aggregates at the Air-Solution Interfaces as Studied by Oriented Crystallization and Nonlinear Optics”J. Am. Chem. Soc., 1990, vol. 112, pp. 5874-5875.
Weissbuch et al. “‘Tailormade’ Auxiliaries for Nucleation, Growth and Dissolution of Organic Crystals”Pure and Appl. Chem., 1986, vol. 58, No. 6, pp. 947-954.
Weissbuch et al., “Towards an Understanding and Control of Nucleation, Growth, Habit, Dissolution, and Structure of Crystals Using ‘Tailor-Made’ Auxiliaries”Molecular Modeling Applications in Crystallization, edited by Allan S. Myerson, Cambridge University Press, 1999, pp. 166-227.
Zander et al. “Mineralization of Dental Calculus”Proceedings of the Society for Experimental Biology andMedicine, 1960, vol. 103, No. 2, pp. 257-261.
Aldridge, P.K. et al., “A Robotic Dissolution System with On-Line Fiber-Optic UV Analysis”,Journal of Pharmaceutical Sciences, 84:8: (1995).
Andersen, G. et al., “A Spreadsheet Approach to Automated Protein Crystallization”,J. Appl. Cryst., 29:236-240 (1996).
Anquetil, P.A. et al., “Laser Raman Spectroscopic Analysis of Polymorphic Forms in Microliter Fluid Volumes”,Journal of Pharmaceut
Epperson Jon D.
Saliwanchik Lloyd & Saliwanchik
Transform Pharmaceuticals Inc.
Wang Andrew
LandOfFree
Rapid identification of conditions, compounds, or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid identification of conditions, compounds, or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid identification of conditions, compounds, or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3538804